Cargando…
Evaluation of FET PET Radiomics Feature Repeatability in Glioma Patients
SIMPLE SUMMARY: Initial studies suggested the additional diagnostic value of amino acid positron emission tomography (PET) radiomics using the tracer O-(2-[(18)F]fluoroethyl)-L-tyrosine (FET) in brain tumor patient management. However, to ensure the reliable performance of the generated FET PET radi...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915742/ https://www.ncbi.nlm.nih.gov/pubmed/33562803 http://dx.doi.org/10.3390/cancers13040647 |
_version_ | 1783657317007360000 |
---|---|
author | Gutsche, Robin Scheins, Jürgen Kocher, Martin Bousabarah, Khaled Fink, Gereon R. Shah, Nadim J. Langen, Karl-Josef Galldiks, Norbert Lohmann, Philipp |
author_facet | Gutsche, Robin Scheins, Jürgen Kocher, Martin Bousabarah, Khaled Fink, Gereon R. Shah, Nadim J. Langen, Karl-Josef Galldiks, Norbert Lohmann, Philipp |
author_sort | Gutsche, Robin |
collection | PubMed |
description | SIMPLE SUMMARY: Initial studies suggested the additional diagnostic value of amino acid positron emission tomography (PET) radiomics using the tracer O-(2-[(18)F]fluoroethyl)-L-tyrosine (FET) in brain tumor patient management. However, to ensure the reliable performance of the generated FET PET radiomics models for clinical diagnostics, repeatability of radiomics features is essential. Hence, we assessed the impact of brain tumor volumes and key molecular alterations such as an isocitrate dehydrogenase (IDH) mutation on the repeatability of FET PET radiomics features in 50 newly diagnosed glioma patients. In a test–retest approach based on routinely acquired FET PET scans, we identified 297 repeatable features. The IDH genotype did not affect feature repeatability. Moreover, these robust features were able to differentiate patients with IDH-wildtype glioma from those with an IDH mutation. Our results suggest that robust radiomics features can be obtained from routinely acquired FET PET scans, which are valuable for further standardization of radiomics analyses in neurooncology. ABSTRACT: Amino acid PET using the tracer O-(2-[(18)F]fluoroethyl)-L-tyrosine (FET) has attracted considerable interest in neurooncology. Furthermore, initial studies suggested the additional diagnostic value of FET PET radiomics in brain tumor patient management. However, the conclusiveness of radiomics models strongly depends on feature generalizability. We here evaluated the repeatability of feature-based FET PET radiomics. A test–retest analysis based on equivalent but statistically independent subsamples of FET PET images was performed in 50 newly diagnosed and histomolecularly characterized glioma patients. A total of 1,302 radiomics features were calculated from semi-automatically segmented tumor volumes-of-interest (VOIs). Furthermore, to investigate the influence of the spatial resolution of PET on repeatability, spherical VOIs of different sizes were positioned in the tumor and healthy brain tissue. Feature repeatability was assessed by calculating the intraclass correlation coefficient (ICC). To further investigate the influence of the isocitrate dehydrogenase (IDH) genotype on feature repeatability, a hierarchical cluster analysis was performed. For tumor VOIs, 73% of first-order features and 71% of features extracted from the gray level co-occurrence matrix showed high repeatability (ICC 95% confidence interval, 0.91–1.00). In the largest spherical tumor VOIs, 67% of features showed high repeatability, significantly decreasing towards smaller VOIs. The IDH genotype did not affect feature repeatability. Based on 297 repeatable features, two clusters were identified separating patients with IDH-wildtype glioma from those with an IDH mutation. Our results suggest that robust features can be obtained from routinely acquired FET PET scans, which are valuable for further standardization of radiomics analyses in neurooncology. |
format | Online Article Text |
id | pubmed-7915742 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-79157422021-03-01 Evaluation of FET PET Radiomics Feature Repeatability in Glioma Patients Gutsche, Robin Scheins, Jürgen Kocher, Martin Bousabarah, Khaled Fink, Gereon R. Shah, Nadim J. Langen, Karl-Josef Galldiks, Norbert Lohmann, Philipp Cancers (Basel) Article SIMPLE SUMMARY: Initial studies suggested the additional diagnostic value of amino acid positron emission tomography (PET) radiomics using the tracer O-(2-[(18)F]fluoroethyl)-L-tyrosine (FET) in brain tumor patient management. However, to ensure the reliable performance of the generated FET PET radiomics models for clinical diagnostics, repeatability of radiomics features is essential. Hence, we assessed the impact of brain tumor volumes and key molecular alterations such as an isocitrate dehydrogenase (IDH) mutation on the repeatability of FET PET radiomics features in 50 newly diagnosed glioma patients. In a test–retest approach based on routinely acquired FET PET scans, we identified 297 repeatable features. The IDH genotype did not affect feature repeatability. Moreover, these robust features were able to differentiate patients with IDH-wildtype glioma from those with an IDH mutation. Our results suggest that robust radiomics features can be obtained from routinely acquired FET PET scans, which are valuable for further standardization of radiomics analyses in neurooncology. ABSTRACT: Amino acid PET using the tracer O-(2-[(18)F]fluoroethyl)-L-tyrosine (FET) has attracted considerable interest in neurooncology. Furthermore, initial studies suggested the additional diagnostic value of FET PET radiomics in brain tumor patient management. However, the conclusiveness of radiomics models strongly depends on feature generalizability. We here evaluated the repeatability of feature-based FET PET radiomics. A test–retest analysis based on equivalent but statistically independent subsamples of FET PET images was performed in 50 newly diagnosed and histomolecularly characterized glioma patients. A total of 1,302 radiomics features were calculated from semi-automatically segmented tumor volumes-of-interest (VOIs). Furthermore, to investigate the influence of the spatial resolution of PET on repeatability, spherical VOIs of different sizes were positioned in the tumor and healthy brain tissue. Feature repeatability was assessed by calculating the intraclass correlation coefficient (ICC). To further investigate the influence of the isocitrate dehydrogenase (IDH) genotype on feature repeatability, a hierarchical cluster analysis was performed. For tumor VOIs, 73% of first-order features and 71% of features extracted from the gray level co-occurrence matrix showed high repeatability (ICC 95% confidence interval, 0.91–1.00). In the largest spherical tumor VOIs, 67% of features showed high repeatability, significantly decreasing towards smaller VOIs. The IDH genotype did not affect feature repeatability. Based on 297 repeatable features, two clusters were identified separating patients with IDH-wildtype glioma from those with an IDH mutation. Our results suggest that robust features can be obtained from routinely acquired FET PET scans, which are valuable for further standardization of radiomics analyses in neurooncology. MDPI 2021-02-05 /pmc/articles/PMC7915742/ /pubmed/33562803 http://dx.doi.org/10.3390/cancers13040647 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Gutsche, Robin Scheins, Jürgen Kocher, Martin Bousabarah, Khaled Fink, Gereon R. Shah, Nadim J. Langen, Karl-Josef Galldiks, Norbert Lohmann, Philipp Evaluation of FET PET Radiomics Feature Repeatability in Glioma Patients |
title | Evaluation of FET PET Radiomics Feature Repeatability in Glioma Patients |
title_full | Evaluation of FET PET Radiomics Feature Repeatability in Glioma Patients |
title_fullStr | Evaluation of FET PET Radiomics Feature Repeatability in Glioma Patients |
title_full_unstemmed | Evaluation of FET PET Radiomics Feature Repeatability in Glioma Patients |
title_short | Evaluation of FET PET Radiomics Feature Repeatability in Glioma Patients |
title_sort | evaluation of fet pet radiomics feature repeatability in glioma patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915742/ https://www.ncbi.nlm.nih.gov/pubmed/33562803 http://dx.doi.org/10.3390/cancers13040647 |
work_keys_str_mv | AT gutscherobin evaluationoffetpetradiomicsfeaturerepeatabilityingliomapatients AT scheinsjurgen evaluationoffetpetradiomicsfeaturerepeatabilityingliomapatients AT kochermartin evaluationoffetpetradiomicsfeaturerepeatabilityingliomapatients AT bousabarahkhaled evaluationoffetpetradiomicsfeaturerepeatabilityingliomapatients AT finkgereonr evaluationoffetpetradiomicsfeaturerepeatabilityingliomapatients AT shahnadimj evaluationoffetpetradiomicsfeaturerepeatabilityingliomapatients AT langenkarljosef evaluationoffetpetradiomicsfeaturerepeatabilityingliomapatients AT galldiksnorbert evaluationoffetpetradiomicsfeaturerepeatabilityingliomapatients AT lohmannphilipp evaluationoffetpetradiomicsfeaturerepeatabilityingliomapatients |